The FDA’s Division of Drug Marketing, Advertising and Communications has issued untitled letters of violation to Schering-Plough for its Nasonex nasal spray, and to GlaxoSmithKline for its Flonase ...

In an April trial Apotex claimed that its spray differs because it will not contain water, Reuters says. With sales just shy of $1.3 billion in 2011, Nasonex allergy spray is Merck's ...

Nasonex is currently approved in more than 100 countries and is anticipated to be available in Japan this fall.Schering-Plough Corp. (NYSE: SGP) of Kenilworth said today that its Japanese unit has ...

DTC TV prescription drug ads featuring an animated bee and a talking beaver were most recalled by consumers during 2007, according to ad performance tracking firm IAG Research. A 30-second spot ...

Last week, on Friday, June 15, 2012, Merck (NYSE: MRK) announced the U.S. District Court for the District of New Jersey (Judge Peter G. Sheridan) ruled against the company on the issue of patent ...

The FDA's new proposed guidelines on drug advertising read like a full-employment act for medical copywriters and graphic designers: they control font size, white space, context, contrast, placement, ...

With spring allergies in the air, two prescription-products-gone-over-the-counter recently – Astepro and Nasonex -- have sprung creative campaigns. Surrounded by flowers, and clothed and posed as if ...

Merck Sharp & Dohme has won an injunction in Australia preventing generic rival Apotex from selling a range of nasal sprays alleged to infringe the IP rights in Merck’s Nasonex product The order comes ...

June 15 (Reuters) - Merck & Co, Inc lost a patent infringement lawsuit against Apotex Inc on Friday over Apotex's plans to market a generic version of the nasal allergy spray Nasonex. Sign up here.

The appointment marks McCann Hong Kong's first health care account. This is also the first time MSD has engaged an advertising agency to market this brand. The creative pitch, which took place in July ...

Last week, on Friday, June 15, 2012, Merck (NYSE: MRK) announced the U.S. District Court for the District of New Jersey (Judge Peter G. Sheridan) ruled against the company on the issue of patent ...

plans to market a generic version of the nasal spray Nasonex. Trump says he won’t fund invasive carp barrier unless Pritzker ‘asks.’ But the money has already been set aside. Trump says he won't fund ...